President's Cancer Panel Meeting: Translating Research to Reduce the Burden of Cancer, Transcript of Proceedings, Columb by National Institute of Cancer . - HTML preview

PLEASE NOTE: This is an HTML preview only and some elements such as links or page numbers may be incorrect.
Download the book in PDF, ePub, Kindle for a complete version.

 

OVERVIEW

The purpose of the meeting, the second of four regional meetings, was to examine barriers to progress in translating cancer research into reductions in suffering and death due to cancer. The President’s Cancer Panel (PCP, the Panel) is seeking input to help develop its recommendations to the President of the United States, the U.S. Congress, the Secretary of Health and Human Services (HHS), and the broader community of researchers, policy makers, advocates, and others.

PARTICIPANTS

President’s Cancer Panel (PCP)

LaSalle D. Leffall, Jr., M.D., F.A.C.S., Chair

Margaret Kripke, Ph.D.

Lance Armstrong

National Cancer Institute ( NCI), National Institutes of Health (NIH)

Maureen O. Wilson, Ph.D., Assistant Director, NCI, and Executive Secretary, PCP

Sarah Birckhead, M.S.W., Special Assistant, Office of the Director, NCI

Heather Kapp, M.S.W., M.P.H., Communications Fellow, PCP

Karen Parker, M.S.W., Special Assistant, PCP

David Pugach, J.D., Legislative Analyst, NCI

Abby Sandler, Ph.D., IRO, NCI

Speakers

Lucile Adams-Campbell, Ph.D., Director and Professor of Medicine, Howard University Cancer Center Bill Bro, CEO, Kidney Cancer Association

Michael A. Caligiuri, M.D., Professor and Director, The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Mark Clanton, M.D., M.P.H., Deputy Director, Cancer Care and Delivery Systems, National Cancer Institute

Robert L. Comis, M.D., President and Chairman, Coalition of National Cancer Cooperative Groups/Group Chair, Eastern Cooperative Oncology Group

Stanton Gerson, M.D., Director, Case Comprehensive Cancer Center and Ireland Cancer Center of University Hospitals of Cleveland, Case Western Reserve University

Gary Gordon, M.D., Ph.D., Divisional Vice President, Global Oncology Development, Abbott Laboratories

Scott Gottlieb, M.D., Senior Advisor to the Administrator, Centers for Medicare and Medicaid Services Michael R. Grever, M.D., Associate Dean for Medical Services, Professor and Chair, Department of Internal Medicine, The Ohio State University Medical Center

Catherine D. Harvey, R.N., Dr.P.H., AOCN, Chair, Board of Directors, National Coalition for Cancer Survivorship

Ronald B. Herberman, M.D., Director, University of Pittsburgh Cancer Institute Clifton Leaf, Executive Editor, FORTUNE Magazine

Homer L. Pearce, Ph.D., Distinguished Research Fellow, Eli Lilly and Company

Stephen M. Prescott, M.D., Executive Director, Huntsman Cancer Institute

Eddie Reed, M.D., Director, Mary Babb Randolph Cancer Center

Paul L. Schaefer, M.D., Principal Investigator, Toledo Community Oncology Program

Harold C. Sox, Jr., M.D., Editor, Annals of Internal Medicine

K. “Vish” Viswanath, Ph.D., Associate Professor of Medical Oncology, Center for Community-Based Research, Dana-Farber Cancer Institute

Steven N. Wolff, M.D., Professor of Medicine, Meharry Medical College

Lisa J. Zimmerman, M.S., Director, Quality Assurance and Regulatory Compliance, Duke Clinical Research Institute